• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

测量肌强直:正常参考值及与1型强直性肌营养不良的比较

Measuring Myotonia: Normative Values and Comparison with Myotonic Dystrophy Type 1.

作者信息

Sipos Andrea, Árvai Milán, Varga Dávid, Ruszin-Perecz Brigitta, Janszky József, Hajdú Nándor, Pál Endre

机构信息

Department of Neurology, Medical School, University of Pécs, 7623 Pécs, Hungary.

Institute of Psychology, Eötvös Loránd University, 1053 Budapest, Hungary.

出版信息

Neurol Int. 2025 Jul 31;17(8):118. doi: 10.3390/neurolint17080118.

DOI:10.3390/neurolint17080118
PMID:40863987
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12389102/
Abstract

INTRODUCTION

Myotonia is a rare neuromuscular condition characterized by impaired muscle relaxation. In this study, we provide normative values for clinical tests related to myotonia in the Hungarian population and compare them to patients with myotonic dystrophy type 1 (DM1).

METHODS

Relaxation tests (10 eye openings, tongue extension, and palm openings), handgrip strength, and the nine-hole peg test were conducted on 139 healthy individuals and 31 patients with DM1.

RESULTS

We observed non-significant declines in handgrip strength and relaxation tests with age ( < 0.05). Significant differences were found between controls (n:139) and patients with DM1 (n = 31) in all tests ( < 0.05). Sex differences were noted in the healthy population: men (n:68/139) had stronger handgrip (mean of men 42.45 ± 1.15 vs. women 24.3 ± 0.9) and slower relaxation tests (mean of eye openings in men 3.6 ± 0.2 vs. in women 4.2 ± 0.2, tongue extensions in men 3.7 ± 0.2 vs. in women 4.2 ± 0.2, palm openings in men 4 ± 0.2 vs. in women 4.9 ± 0.2 However, these differences were not present among patients with DM1.

DISCUSSION

Normal values for relaxation tests across different age groups were established. These results might be useful for further clinical investigations. Our study supports the usage of averages of healthy population instead of age groups of relaxation tests and their clinical relevance in the evaluation of patients with myotonia.

摘要

引言

肌强直是一种罕见的神经肌肉疾病,其特征为肌肉放松受损。在本研究中,我们提供了匈牙利人群中与肌强直相关的临床测试的标准值,并将其与1型强直性肌营养不良(DM1)患者进行比较。

方法

对139名健康个体和31名DM1患者进行了放松测试(10次睁眼、伸舌和张掌)、握力测试和九孔插板测试。

结果

我们观察到握力和放松测试随年龄增长无显著下降(<0.05)。在所有测试中,对照组(n = 139)和DM1患者(n = 31)之间存在显著差异(<0.05)。在健康人群中注意到了性别差异:男性(n = 68/139)握力更强(男性平均值42.45±1.15,女性为24.3±0.9),放松测试更慢(男性睁眼平均值3.6±0.2,女性为4.2±0.2;男性伸舌平均值3.7±0.2,女性为4.2±0.2;男性张掌平均值4±0.2,女性为4.9±0.2)。然而,这些差异在DM1患者中不存在。

讨论

建立了不同年龄组放松测试的正常值。这些结果可能对进一步的临床研究有用。我们的研究支持在评估肌强直患者时使用健康人群的平均值而非年龄组的放松测试及其临床相关性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba3d/12389102/47cb6ced42c4/neurolint-17-00118-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba3d/12389102/03d8069f0804/neurolint-17-00118-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba3d/12389102/b0cdebfe178b/neurolint-17-00118-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba3d/12389102/c5b0d4c688f8/neurolint-17-00118-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba3d/12389102/47cb6ced42c4/neurolint-17-00118-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba3d/12389102/03d8069f0804/neurolint-17-00118-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba3d/12389102/b0cdebfe178b/neurolint-17-00118-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba3d/12389102/c5b0d4c688f8/neurolint-17-00118-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba3d/12389102/47cb6ced42c4/neurolint-17-00118-g004.jpg

相似文献

1
Measuring Myotonia: Normative Values and Comparison with Myotonic Dystrophy Type 1.测量肌强直:正常参考值及与1型强直性肌营养不良的比较
Neurol Int. 2025 Jul 31;17(8):118. doi: 10.3390/neurolint17080118.
2
Drug treatment for myotonia.肌强直的药物治疗。
Cochrane Database Syst Rev. 2025 Apr 8;4(4):CD004762. doi: 10.1002/14651858.CD004762.pub3.
3
Assessing the Safety and Efficacy of Lamotrigine as Anti-myotonic Agent in Myotonic Dystrophy Type 1 (DM1): A Longitudinal, Open-Label, Pilot Study.评估拉莫三嗪作为1型强直性肌营养不良症(DM1)抗肌强直药物的安全性和有效性:一项纵向、开放标签的试点研究。
Neurol Ther. 2025 Oct;14(5):2249-2260. doi: 10.1007/s40120-025-00804-z. Epub 2025 Aug 2.
4
Drug treatment for myotonia.肌强直的药物治疗。
Cochrane Database Syst Rev. 2006 Jan 25;2006(1):CD004762. doi: 10.1002/14651858.CD004762.pub2.
5
Behavioral interventions to reduce risk for sexual transmission of HIV among men who have sex with men.降低男男性行为者中艾滋病毒性传播风险的行为干预措施。
Cochrane Database Syst Rev. 2008 Jul 16(3):CD001230. doi: 10.1002/14651858.CD001230.pub2.
6
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.系统性药理学治疗慢性斑块状银屑病:网络荟萃分析。
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.
7
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
8
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状荟萃分析。
Cochrane Database Syst Rev. 2017 Dec 22;12(12):CD011535. doi: 10.1002/14651858.CD011535.pub2.
9
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状Meta分析。
Cochrane Database Syst Rev. 2020 Jan 9;1(1):CD011535. doi: 10.1002/14651858.CD011535.pub3.
10
Sertindole for schizophrenia.用于治疗精神分裂症的舍吲哚。
Cochrane Database Syst Rev. 2005 Jul 20;2005(3):CD001715. doi: 10.1002/14651858.CD001715.pub2.

本文引用的文献

1
Simple and economical HandClench Relaxometer device for reliable and sensitive measurement of grip myotonia in myotonic dystrophy.用于可靠且灵敏地测量强直性肌营养不良症握力性肌强直的简单经济的手部紧握放松计装置。
Neuromuscul Disord. 2022 Apr;32(4):321-331. doi: 10.1016/j.nmd.2022.02.005. Epub 2022 Feb 14.
2
Assessment of muscular strength and functional capacity in the juvenile and adult myotonic dystrophy type 1 population: a 3-year follow-up study.1 型先天性肌强直性营养不良青少年和成年人群的肌肉力量和功能能力评估:一项 3 年随访研究。
J Neurol. 2021 Nov;268(11):4221-4237. doi: 10.1007/s00415-021-10533-6. Epub 2021 Apr 27.
3
Analysis of the functional capacity outcome measures for myotonic dystrophy.
肌强直性营养不良的功能能力结局测量分析。
Ann Clin Transl Neurol. 2019 Aug;6(8):1487-1497. doi: 10.1002/acn3.50845. Epub 2019 Jul 22.
4
Quantitative myotonia assessment with a commercially available dynamometer in myotonic dystrophy types 1 and 2.使用市售测力计对 1 型和 2 型肌强直性营养不良进行定量肌强直评估。
Muscle Nerve. 2019 Apr;59(4):431-435. doi: 10.1002/mus.26401. Epub 2019 Jan 9.
5
Validation of the Nine Hole Peg Test as a measure of dexterity in myotonic dystrophy type 1.验证九孔钉测试作为肌强直性营养不良症 1 型灵巧度的测量方法。
Neuromuscul Disord. 2018 Nov;28(11):947-951. doi: 10.1016/j.nmd.2018.08.011. Epub 2018 Aug 31.
6
A 9-year follow-up study of quantitative muscle strength changes in myotonic dystrophy type 1.1 型强直性肌营养不良症定量肌肉力量变化的 9 年随访研究。
J Neurol. 2018 Jul;265(7):1698-1705. doi: 10.1007/s00415-018-8898-4. Epub 2018 May 21.
7
Core Clinical Phenotypes in Myotonic Dystrophies.强直性肌营养不良的核心临床表型
Front Neurol. 2018 May 2;9:303. doi: 10.3389/fneur.2018.00303. eCollection 2018.
8
The Nine-Hole Peg Test as a manual dexterity performance measure for multiple sclerosis.九孔插板测试作为多发性硬化症手部灵巧性的一项性能指标。
Mult Scler. 2017 Apr;23(5):711-720. doi: 10.1177/1352458517690824. Epub 2017 Feb 16.
9
Is one trial enough for repeated testing? Same-day assessments of walking, mobility and fine hand use in people with myotonic dystrophy type 1.一次试验就足以进行重复测试吗?对1型强直性肌营养不良患者的步行、活动能力和精细手部使用进行同日评估。
Neuromuscul Disord. 2017 Feb;27(2):153-158. doi: 10.1016/j.nmd.2016.11.018. Epub 2016 Dec 5.
10
A review of muscle- and performance-based assessment instruments in DM1.对1型糖尿病中基于肌肉和表现的评估工具的综述。
Muscle Nerve. 2017 Jul;56(1):78-85. doi: 10.1002/mus.25468. Epub 2017 Mar 1.